GeNeuro (XPAR:GNRO) COGS-to-Revenue : 0.00 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is GeNeuro COGS-to-Revenue?

GeNeuro's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was €0.00 Mil.

GeNeuro's COGS to Revenue for the six months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. GeNeuro's Gross Margin % for the six months ended in Dec. 2023 was N/A%.

GeNeuro COGS-to-Revenue Historical Data

The historical data trend for GeNeuro's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeNeuro COGS-to-Revenue Chart

GeNeuro Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

GeNeuro Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

GeNeuro COGS-to-Revenue Calculation

GeNeuro's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

GeNeuro's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

GeNeuro (XPAR:GNRO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

GeNeuro's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

GeNeuro COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of GeNeuro's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

GeNeuro Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (XPAR:GNRO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

GNROp:UK GEM:Germany

Address

3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.geneuro.com

GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).

GeNeuro Headlines

No Headlines